Reported Reactions

Devices › Stimulator, hypoglossal nerve, implanted, apnea

Device brand name · Inspire v ipg model 3150

Inspire V IPG Model 3150: medical device reports filed with FDA

166 reports name it, 2025–2026. Manufacturer given most often on reports: Inspire Medical Systems. Product code MNQ.

166
device reports naming the brand
0% of all MAUDE reports · about 166 a year
163
reports, 12 months to August 2026
3 in the 12 months before
0%
classified as malfunction
4.5% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 166 reports that name the brand "Inspire V IPG Model 3150" (inspire v ipg model 3150), received between July 2025 and August 2026; the manufacturer given most often on reports is Inspire Medical Systems. Spellings of one product vary from report to report.

163 reports arrived in the 12 months to August 2026, up 5333% from 3 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all stimulator, hypoglossal nerve, implanted, apnea reports (product code MNQ) death is recorded in 0.1% and malfunction in 4.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are migration (17.5%), migration or expulsion of device (2.4%) and expulsion (1.8%). The patient problems coded most often are wound dehiscence, inflammation and hematoma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01224Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 2Aug 2025: 1Sep 2025: 3Oct 2025: 3Nov 2025: 11Dec 2025: 132026Jan 2026: 15Feb 2026: 14Mar 2026: 15Apr 2026: 16May 2026: 16Jun 2026: 24Jul 2026: 16Aug 2026: 17

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%166
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%166
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,571 reports carrying product code MNQ. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Migrationthe device moved from where it was placed2917.5%6%
Migration or expulsion of device42.4%4.6%
Expulsion31.8%1.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Wound dehiscencea wound reopened2816.9%
Inflammationinflammation2716.3%
Hematomaa collection of blood under the skin or in tissue2615.7%
Medical device site infectioninfection at the device site2414.5%
Painpain, site not specified2313.9%
Purulent discharge1810.8%
Fluid discharge169.6%
Swelling/ edema148.4%
Implant pain137.8%
Seromaa collection of fluid under the skin84.8%
Twiddlers syndrome42.4%
Erosion31.8%
Pocket erosion31.8%
Rashskin rash31.8%
Abscessa collection of pus21.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureInspire V IPG Model 3150Product code MNQAll MAUDE reports
Reports1663,57126,136,888
Share of that pool—4.6%0%
Classified as death, per 1,000 reports019
Classified as injury100%95.3%36.2%
Classified as malfunction0%4.5%62.3%
Filed by the manufacturer100%95%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code MNQ

BrandReportsLatest 12 monthsClassified as death
Inspire Model 3028 IPG1,4372980.3%
Inspire Model 4063 Stimulation Lead1,3134260%
Inspire Model 4340 Respiratory Sensing Lead272360%
Dexcom G71,3945830.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Inspire V IPG Model 3150 reports

How many FDA reports name Inspire V IPG Model 3150?

166 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 163 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

migration (17.5%), migration or expulsion of device (2.4%) and expulsion (1.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Inspire V IPG Model 3150 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.